extended follow-up of the master trial
Published 1 year ago • 107 plays • Length 2:17Download video MP4
Download video MP3
Similar videos
-
3:43
mrd-guided treatment cessation in multiple myeloma
-
1:42
immune profiling & mrd negativity of ndmm treated with quadruplet induction autosct: milestone trial
-
2:37
evidence supporting mrd-guided treatment breaks in mm
-
1:38
using mrd to guide therapy in multiple myeloma
-
1:00
quadruplet induction therapy in newly diagnosed high-risk myeloma
-
2:27
mrd-guided therapy in multiple myeloma
-
1:07
mrd-guided treatment in multiple myeloma
-
1:46
standardization mrd monitoring in clinical trials
-
1:15
using mrd to guide treatment decisions in myeloma
-
2:09
mrd in multiple myeloma: prognosis, a clinical trial endpoint, and guiding treatment decisions
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
1:05
are we ready for mrd-guided therapy in multiple myeloma?
-
1:22
an overview of clinical trials investigating btk inhibitors and degraders in mcl
-
9:57
quadruplet therapies for treating mm: the current evidence and the findings of a phase ii trial
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space
-
0:58
dara-rvd in the treatment of hr-smm: an ongoing phase ii trial
-
1:41
dara-rvd, with an mrd-adaptive duration of therapy, in high-risk smoldering myeloma
-
0:36
the potential of immunotherapies in the myeloma treatment landscape